Abstract: Poster Presentations |


Edgar V. Garcia Badillo, MD*; Carlos Jerjes Sanchez, MD; Alicia Ramirez Rivera, MD; Susana Ramirez Rivera, MD
Author and Funding Information

Unidad De Investigacion Clinica En Medicina Sc, Monterrey, Mexico


Chest. 2008;134(4_MeetingAbstracts):p136003. doi:10.1378/chest.134.4_MeetingAbstracts.p136003
Text Size: A A A
Published online


PURPOSE: The goal of this study was to evaluate the predicitive value of brain natriuretic peptide (BNP) for adverse cardiovascular events (ACE) in pulmonary arterial hypertension (PAH) patients.

METHODS: We conducted a prospective, controlled trial. Study population: Patients with idiopathic PAH, or PAH associated with congenital cardiac diseases, collagen vascular diseases, anorexigen use, pulmonary embolism and human immunodeficiency virus infection with mean pulmonary arterial pressure (mPAP) >25 mmHg by right cardiac catheterization. In all patients determination of BNP and 6 minute walk distance test (6MWDT) were done the same day. Exclusion criteria was: absense of BNP determination. Control group: healhty patients paired by gender, age and weight. Statistical analysis: Student's t, logistic and multiple regression, Wilcoxon test, proportional risk Cox model, square chi.

RESULTS: From March to November 2007, 85 patients, 20% male and 80% female with a mean age of 37.8 ±14 years were included in the study. PAH was associated with cardiac congenital diseases 40% (ASD 29%, VSD 6%, PDA 5%), idiopathic 40%, collagen vascular diseases 12%, pulmonary embolism 4%, anorexigen use 2%, immunodeficiency virus infection 2%. In all patients we evaluated ACE: right ventricular dysfunction, heart failure, cardiogenic shock and death. mPAP 90.40 ±27.50 mmHg, 6MWDT 419 ±103.8 meters, BNP 167.66 ±218.29 pg/mL and control group (33 patients) BNP 12.11 ±8.9 pg/mL (p<0.0001). Simple regression analysis identified BNP as an independent variable for ACE (p<0.001). The logistic regression models and multivariate analysis which included BNP had the greatest correlation (r=0.48) compared to historic models.

CONCLUSION: In this group of patients with PAH, BNP was an independent variable with a high predictive value for ACE.

CLINICAL IMPLICATIONS: This tool could improve the risk stratification and identify risk patients in an attempt to develop strategies for primary or secondary prevention measures.

DISCLOSURE: Edgar Garcia Badillo, No Financial Disclosure Information; No Product/Research Disclosure Information

Wednesday, October 29, 2008

1:00 PM - 2:15 PM




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543